Close Menu

NEW YORK – Shares of Twist Bioscience rose 12 percent in afternoon trading on the Nasdaq on speculation that the synthetic DNA manufacturer is close to settling a trade secrets lawsuit filed by Agilent Technologies.

The San Francisco-based company's stock opened Thursday trading at $26.83 and the shares rose sharply in mid-afternoon trade to $30.11.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.